Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Receivables - Net: 2013-2025

Historic Receivables - Net for Ocular Therapeutix (OCUL) over the last 12 years, with Sep 2025 value amounting to $30.8 million.

  • Ocular Therapeutix's Receivables - Net rose 1.76% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.8 million, marking a year-over-year increase of 1.76%. This contributed to the annual value of $32.4 million for FY2024, which is 23.72% up from last year.
  • As of Q3 2025, Ocular Therapeutix's Receivables - Net stood at $30.8 million, which was up 1.17% from $30.4 million recorded in Q2 2025.
  • Over the past 5 years, Ocular Therapeutix's Receivables - Net peaked at $32.4 million during Q4 2024, and registered a low of $13.6 million during Q1 2021.
  • Moreover, its 3-year median value for Receivables - Net was $27.3 million (2023), whereas its average is $27.6 million.
  • Per our database at Business Quant, Ocular Therapeutix's Receivables - Net soared by 551.84% in 2021 and then dropped by 8.98% in 2023.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Receivables - Net stood at $21.1 million in 2021, then rose by 0.90% to $21.3 million in 2022, then grew by 22.76% to $26.2 million in 2023, then rose by 23.72% to $32.4 million in 2024, then increased by 1.76% to $30.8 million in 2025.
  • Its Receivables - Net was $30.8 million in Q3 2025, compared to $30.4 million in Q2 2025 and $25.2 million in Q1 2025.